Skip to main content
Premium Trial:

Request an Annual Quote

GE Healthcare to Lay Off 120 Staffers from Sunnyvale Facility

NEW YORK, March 8 (GenomeWeb News) - GE Healthcare will lay off as many as 120 workers next week from its Sunnyvale, Calif., facility, according to the California Employment Development Department.

 

According to a listing of Worker Adjustment and Retraining Notification act notices provided by CEDD, GE Healthcare is to lay off 120 of its Sunnyvale employees as of March 14.

 

The Sunnyvale facility served as the birthplace of Amersham Bioscience's MegaBace DNA-sequencing technology and other genomics technologies.

 

A US-based spokesperson for GE Healthcare was not immediately able to confirm or comment regarding the potential lay-offs. It is unclear how many total GE Healthcare employees are based at the Sunnyvale facility.

 

BioCommerce Week, a GenomeWeb publication,  reported in January that the facility would likely be downsized as part of GE Healthcare's ongoing integration of Amersham Bioscience, and that the unit's development workers were offered transfers to GE Healthcare's offices in Piscataway, NJ.

 

However, it was unclear at the time if, or how many lay-offs would occur.

 

The Sunnyvale facility was originally the home of Molecular Dynamics, which Amersham acquired in 1998, according to BioCommerce Week. It most recently housed marketing and management operations for Amersham.

The Scan

Not as High as Hoped

The Associated Press says initial results from a trial of CureVac's SARS-CoV-2 vaccine suggests low effectiveness in preventing COVID-19.

Finding Freshwater DNA

A new research project plans to use eDNA sampling to analyze freshwater rivers across the world, the Guardian reports.

Rise in Payments

Kaiser Health News investigates the rise of payments made by medical device companies to surgeons that could be in violation of anti-kickback laws.

Nature Papers Present Ginkgo Biloba Genome Assembly, Collection of Polygenic Indexes, More

In Nature this week: a nearly complete Ginkgo biloba genome assembly, polygenic indexes for dozens of phenotypes, and more.